1. Home
  2. GROW vs CASI Comparison

GROW vs CASI Comparison

Compare GROW & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • CASI
  • Stock Information
  • Founded
  • GROW 1968
  • CASI 1991
  • Country
  • GROW United States
  • CASI China
  • Employees
  • GROW N/A
  • CASI N/A
  • Industry
  • GROW Investment Managers
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • CASI Health Care
  • Exchange
  • GROW Nasdaq
  • CASI Nasdaq
  • Market Cap
  • GROW 32.2M
  • CASI 35.8M
  • IPO Year
  • GROW N/A
  • CASI 1996
  • Fundamental
  • Price
  • GROW $2.57
  • CASI $1.78
  • Analyst Decision
  • GROW
  • CASI Strong Buy
  • Analyst Count
  • GROW 0
  • CASI 1
  • Target Price
  • GROW N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • GROW 55.3K
  • CASI 293.0K
  • Earning Date
  • GROW 11-06-2025
  • CASI 11-13-2025
  • Dividend Yield
  • GROW 3.50%
  • CASI N/A
  • EPS Growth
  • GROW N/A
  • CASI N/A
  • EPS
  • GROW N/A
  • CASI N/A
  • Revenue
  • GROW $8,452,000.00
  • CASI $31,564,000.00
  • Revenue This Year
  • GROW N/A
  • CASI N/A
  • Revenue Next Year
  • GROW N/A
  • CASI N/A
  • P/E Ratio
  • GROW N/A
  • CASI N/A
  • Revenue Growth
  • GROW N/A
  • CASI 36.64
  • 52 Week Low
  • GROW $2.02
  • CASI $1.09
  • 52 Week High
  • GROW $2.78
  • CASI $6.50
  • Technical
  • Relative Strength Index (RSI)
  • GROW 48.80
  • CASI 47.42
  • Support Level
  • GROW $2.55
  • CASI $1.75
  • Resistance Level
  • GROW $2.72
  • CASI $1.96
  • Average True Range (ATR)
  • GROW 0.08
  • CASI 0.19
  • MACD
  • GROW -0.02
  • CASI 0.00
  • Stochastic Oscillator
  • GROW 11.36
  • CASI 60.23

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: